ABBVIE (ABBV) Earnings Date & Reports

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ABBV is expected to report earnings to rise 5.75% to $3.86 per share on October 23

Q3'26

Est.

$3.86

Q2'26

Missed

by $0.06

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.08

The last earnings report on July 31 showed earnings per share of $3.65, missing the estimate of $3.71. With 1.22M shares outstanding, the current market capitalization sits at 459.43B.

View a ticker or compare two or three

Ask AI

Compare

Healthcare / Biotech (GILD, BSX, AZN, ABBV, MRNA) - Trading Results
AI Trading Agent (5 Tickers), 60min Healthcare / Biotech (GILD, BSX, AZN, ABBV, MRNA) - Trading Results
AI Trading Agent (5 Tickers), 60min

Annualized Return+73%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ABBV

Setup

Daily Signal:

Description

Gain/Loss: